Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8 Lysine Vasopressin
2. 8-lysine Vasopressin
3. Diapid
4. Lys Vasopressin
5. Lys-vasopressin
6. Lysine Vasopressin
7. Lysyl Vasopressin
8. Postacton
9. Vasopressin, 8-lysine
10. Vasopressin, Lysine
11. Vasopressin, Lysyl
1. Lysine Vasopressin
2. Lysipressin
3. Syntopressin
4. 50-57-7
5. Postacton
6. Diapid
7. Lysine Pitressin
8. 8-l-lysinevasopressin
9. L-lysine Vasopressin
10. Vasopressin-8-lysine
11. Vasopressin Pig
12. Vasopressin, 8-l-lysine-
13. (8-lysine)vasopressin
14. Vasopressin, 8-l-lysine
15. Vasopressin (lysine Form)
16. [lys8]-vasopressin
17. 8-l-lysine Vasopressin
18. 50-57-7 (free Base)
19. [8-lysine]vasopressin
20. Lysine-vasopressin
21. Dsstox_cid_28501
22. Dsstox_rid_82773
23. Dsstox_gsid_48575
24. L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1->6)-disulfide
25. Lipressina
26. Lypressine
27. Lypressinum
28. Lysopressin
29. Lipresina
30. Lysylvasopressin
31. (lys8)-vasopressin
32. Cas-50-57-7
33. (s)-n-((s)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
34. L-8
35. Lipressina [dcit]
36. Lipresina [inn-spanish]
37. Lypressine [inn-french]
38. Lypressinum [inn-latin]
39. Unii-7czf3l922y
40. 3-(phenylalanine)-8-lysine Oxytocin
41. L-lysinamide,
42. Lysine-adh
43. Lypressin [usan:usp:inn:ban]
44. Ncgc00181743-01
45. Ncgc00181743-02
46. Lvp
47. Einecs 200-050-5
48. Brn 4648365
49. [lys8]avp
50. Schembl33287
51. 7czf3l922y
52. Gtpl2172
53. Chembl1200690
54. Dtxsid8048575
55. Chebi:94802
56. Cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2, Cyclic 1-6 Disulfide
57. Hy-p0004
58. Tox21_112902
59. Tox21_113427
60. [lys8]-vasopressinlysine Vasopressin
61. Mfcd00076754
62. Ccg-270620
63. Cs-5838
64. Db14642
65. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
66. Oxytocin, 3-(l-phenylalanine)-8-l-lysine-
67. Vasopressin, 8-l-lysine- (7ci,8ci,9ci)
68. C75370
69. L]carbonyl]-l-prolyl-n-(2-amino-2-oxoethyl)-
70. 076l754
71. Brd-k93331255-001-01-2
72. Q27082434
73. 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide
74. Cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2[disulfide Bridge: 1-6]
75. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
76. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide
77. 1-[[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y
78. 1-{[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-l-p Rolyl-l-lysylglycinamide
79. 19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6ci)
80. Glycinamide, L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysyl-, Cyclic (1>6)-disulfide
81. L 8
82. L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1-6)-disulfide
Molecular Weight | 1056.2 g/mol |
---|---|
Molecular Formula | C46H65N13O12S2 |
XLogP3 | -3.9 |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 19 |
Exact Mass | 1055.43170691 g/mol |
Monoisotopic Mass | 1055.43170691 g/mol |
Topological Polar Surface Area | 476 Ų |
Heavy Atom Count | 73 |
Formal Charge | 0 |
Complexity | 1960 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antidiuretic Agents
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
H - Systemic hormonal preparations, excl. sex hormones and insulins
H01 - Pituitary and hypothalamic hormones and analogues
H01B - Posterior pituitary lobe hormones
H01BA - Vasopressin and analogues
H01BA03 - Lypressin
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?